EP4051265
FUNCTIONALIZED PEPTIDES CONTAINING TWO PYRROLIDINE RINGS AS ANTICORONAVIRUS AGENTS
Anmelder
ENANTA PHARM INC [US]
Erfinder
PANARESE JOSEPH D [US]DAVIS DEXTER [US]KENTON NATHANIEL THOMAS [US]BARTLETT SAMUEL [US]RAFFERTY SEAN [US]OR YAT SUN [US]
Externe Quellen
Klassifikation
IPC-Klassen
A61P 31/00A61K 31/4155C07D 207/27A61P 31/14C07D 401/14C07D 403/12C07D 405/14C07K 5/02C07K 5/06
CPC-Klassen
A61K 31/4025A61K 31/403A61K 31/404A61K 31/4045A61K 31/4155A61K 31/454A61K 38/00A61P 31/14C07D 401/14C07D 403/12C07D 403/14C07D 405/14C07K 5/02C07K 5/0202C07K 5/06C07K 5/06139C07K 5/06165C07K 5/0823
AI: Life Sciences
warum
Enanta antiviral peptide — A61P31/14 + C07K. Pure pharma.